Hospital Universitario de Valladolid -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2022

  1. Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  2. Genetic susceptibility to acute kidney injury

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  3. Regression modeling of the antioxidant-to-nephroprotective relation shows the pivotal role of oxidative stress in cisplatin nephrotoxicity

    Antioxidants, Vol. 10, Núm. 9

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

2016

  1. Mechanisms of triple whammy acute kidney injury

    Pharmacology and Therapeutics, Vol. 167, pp. 132-145

2014

  1. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2007

  1. Launching a clinical program of stem cell therapy for cardiovascular repair

    Nature Clinical Practice Cardiovascular Medicine, Vol. 4, Núm. SUPPL. 1

2003

  1. Immunophenotypic analysis of Waldenstrom's macroglobulinemia

    Seminars in Oncology, Vol. 30, Núm. 2, pp. 187-195